-
Study aim
-
The effect of herbal product from Berberis integerrima on ultrasound image echogenicity of patients with Non-Alcoholic Fatty Liver Disease
-
Design
-
Two arm parallel group randomized trial double blinded clinical trial (III), 60 patients
The method of randomization in this study is quadruple blocking method and the randomization unit is individual and tool is statistical software
-
Settings and conduct
-
After reviewing the inclusion and exclusion criteria and receiving informed consent for participating, the patients Will be divided to two group are provided and asked to consume 2 spoon syrup daily after breakfast and dinner for three months and then ultrasound and lab tests will be repeated.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patients aged 20 to 60 years with increased hepatic echogenicity (grade 2 non-alcoholic fatty liver) based on ultrasonographic findings
Exclusion criteria: Type 2 DM; cardiovascular disease, liver disease; other serious diseases such as cancer; kidney failure and celiac disease, etc .; pregnancy; lactation, taking drugs that cause and stimulate liver steatosis; taking any type of lipid-lowering drugs and fibrates; existence of malnutrition; adherence to special diets such as vegetarianism and raw eating; Alcohol, cigarettes and drugs, acute or underlying psychiatric disorders
Drop out criteria:
Tendency to leave the plan, do not take medication for a week, drug allergy, occurrence of pregnancy, Non-compliance with dietary instructions more than 30%.
-
Intervention groups
-
The control group: placebo syrup contained simple syrup with 2.5% of the studied extract
Intervention group: Barberry-based herbal syrup (75mg/ml), 2 spoon (10ml) per day
-
Main outcome variables
-
Treatment protocol, degree of fatty liver, AST, ALT, age, sex